Becton Dickinson key statistics and ratios
In fiscal 2025, Becton Dickinson had return on equity of 6.5%, an operating margin of 11.8%, debt equal to 75.5% of equity and a current ratio of 1.11. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2009Sept 2009 | 2010Sept 2010 | 2011Sept 2011 | 2012Sept 2012 | 2013Sept 2013 | 2014Sept 2014 | 2015Sept 2015 | 2016Sept 2016 | 2017Sept 2017 | 2018Sept 2018 | 2019Sept 2019 | 2020Sept 2020 | 2021Sept 2021 | 2022Sept 2022 | 2023Sept 2023 | 2024Sept 2024 | 2025Sept 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 52.6% | 51.9% | 52.2% | 51.3% | 51.8% | 50.9% | 45.7% | 48.0% | 49.1% | 45.5% | 47.9% | 47.1% | 45.1% | 44.9% | 42.2% | 45.2% | 45.4% | 46.9% |
| Operating margin | 22.8% | 22.2% | 22.0% | 20.2% | 15.6% | 19.0% | 10.4% | 11.5% | 12.6% | 9.4% | 10.2% | 5.7% | 11.8% | 12.1% | 10.9% | 11.9% | 11.8% | 10.7% |
| Net margin | 17.6% | 18.5% | 16.8% | 15.2% | 16.1% | 14.0% | 6.8% | 7.8% | 9.1% | 1.9% | 7.1% | 5.4% | 10.9% | 9.4% | 7.7% | 8.4% | 7.7% | 4.0% |
| Free-cash-flow margin | 15.4% | 14.8% | 14.9% | 15.6% | 14.8% | 13.7% | 11.0% | 14.9% | 15.1% | 12.3% | 13.7% | 17.2% | 18.0% | 7.9% | 10.9% | 15.5% | 12.2% | 13.8% |
| Return on equity | 23.9% | 24.9% | 24.8% | 26.1% | 28.2% | 23.5% | 11.4% | 13.2% | 10.7% | 1.8% | 5.9% | 3.9% | 8.8% | 7.3% | 5.8% | 6.6% | 6.5% | 3.8% |
| Return on assets | 13.2% | 13.9% | 12.7% | 10.7% | 11.0% | 9.7% | 3.6% | 3.7% | 3.5% | 0.7% | 2.3% | 1.7% | 3.9% | 3.3% | 2.8% | 3.1% | 3.0% | 1.8% |
| Asset turnover | 0.75 | 0.75 | 0.76 | 0.71 | 0.69 | 0.69 | 0.53 | 0.48 | 0.38 | 0.35 | 0.33 | 0.30 | 0.35 | 0.35 | 0.37 | 0.37 | 0.39 | 0.44 |
| Current ratio | 2.61 | 2.70 | 2.56 | 2.69 | 2.76 | 2.74 | 1.29 | 1.45 | 5.58 | 1.03 | 1.18 | 1.54 | 1.33 | 1.04 | 1.31 | 1.17 | 1.11 | 0.87 |
| Debt to equity | 36.8% | 31.2% | 56.3% | 100.7% | 78.7% | 78.6% | 179.0% | 151.3% | 145.7% | 102.4% | 92.0% | 75.5% | 74.4% | 63.5% | 61.6% | 77.7% | 75.5% | 68.8% |
| Interest cover (operating income ÷ interest) | 39.4x | 30.9x | 19.8x | 11.5x | 9.1x | 11.9x | 2.9x | 3.7x | 2.9x | 2.1x | 2.8x | 1.7x | 4.8x | 5.7x | 4.7x | 4.5x | 4.2x | 4.2x |
| Effective tax rate | 26.1% | 28.8% | 25.8% | 24.7% | 20.3% | 22.1% | 6.0% | 9.0% | −12.7% | 73.5% | −4.8% | 15.0% | 5.2% | 8.3% | 7.9% | 15.0% | 10.8% | 12.3% |
| R&D as % of revenue | 5.8% | 5.9% | 6.2% | 6.1% | 6.1% | 6.5% | 6.1% | 6.6% | 6.4% | 6.3% | 6.1% | 6.5% | 6.7% | 6.7% | 6.4% | 5.9% | 5.8% | 5.9% |
| SG&A as % of revenue | 24.1% | 23.7% | 24.1% | 24.9% | 30.1% | 25.4% | 24.9% | 24.1% | 24.1% | 25.1% | 25.1% | 26.0% | 24.7% | 25.0% | 24.4% | 24.1% | 24.2% | 24.6% |
| Capital spending as % of revenue | 8.4% | 7.5% | 6.7% | 6.3% | 6.5% | 7.0% | 5.8% | 5.6% | 6.0% | 5.6% | 5.5% | 4.8% | 6.2% | 5.2% | 4.5% | 3.6% | 3.5% | 3.2% |
| Free cash flow ÷ net income | 87.1% | 80.1% | 88.8% | 103.1% | 92.4% | 97.4% | 163.2% | 191.2% | 165.7% | 633.4% | 192.5% | 316.9% | 165.1% | 84.2% | 142.6% | 182.9% | 159.1% | 340.4% |
| Dividends ÷ net income | 25.7% | 26.2% | 28.4% | 31.5% | 29.9% | 35.5% | 69.8% | 57.6% | 61.5% | 298.1% | 79.8% | 117.4% | 50.1% | 60.8% | 75.1% | 64.5% | 71.3% | 124.5% |
| Dividends and buybacks ÷ free cash flow | 80.8% | 103.8% | 164.8% | 154.9% | 70.0% | 71.1% | 42.8% | 30.1% | 49.2% | 47.1% | 41.5% | 37.0% | 81.0% | 105.6% | 52.6% | 51.3% | 82.2% | 114.6% |
| Quarter | 2024 Q4Sept 2024 | 2025 Q1Dec 2024 | 2025 Q2Mar 2025 | 2025 Q3Jun 2025 | 2025 Q4Sept 2025 | 2026 Q1Dec 2025 | 2026 Q2Mar 2026 | 2026 Q3Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 45.7% | 43.2% | 41.5% | 47.3% | 48.6% | 45.9% | 45.7% | 46.5% |
| Operating margin | 11.4% | 8.8% | 8.5% | 15.6% | 14.1% | 10.5% | 2.0% | 13.3% |
| Net margin | 7.4% | 5.9% | 6.9% | 12.1% | 5.9% | 7.3% | −6.6% | 7.6% |
| Free-cash-flow margin | 16.2% | 11.4% | −7.1% | 19.6% | 17.8% | 10.5% | 11.6% | 12.7% |
| Current ratio | 1.17 | 1.13 | 1.13 | 1.10 | 1.11 | 1.05 | 0.94 | 0.87 |
| Debt to equity | 77.7% | 74.4% | 76.3% | 75.9% | 75.5% | 77.3% | 71.6% | 68.8% |
| R&D as % of revenue | 5.6% | 6.6% | 5.2% | 4.9% | 6.7% | 5.8% | 5.3% | 5.2% |
| SG&A as % of revenue | 23.1% | 25.5% | 24.9% | 24.6% | 22.2% | 26.5% | 25.7% | 25.3% |
Financial health
- Short-term assets cover short-term liabilities $8.1bn of assets due within a year against $9.4bn of liabilities due within a year.
- Short-term assets cover long-term liabilities Not assessable from the reported split. Not assessable.
- More cash than debt $708m of cash against $16.8bn of debt.
- Debt below 40% of shareholders' equity Debt is 69% of equity.
- Debt burden no higher than five years ago Debt to equity moved from 68% to 69% over five years.
- A year's operating cash flow covers at least 20% of debt $4.0bn of operating cash flow against $16.8bn of debt.
- Operating profit covers interest at least five times over Operating income of $2.5bn against $589m of interest.
Moat
Strong moat
How hard Becton Dickinson's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
- Returns on capital 8 / 20
Cash operating profit has been a median 7.0% of total assets over 10 years.
- Pricing power 16 / 20
Gross margin has been a median 45.4%, moving by 1.9 percentage points (standard deviation) across 10 years.
- Durability 12 / 20
Operating margin has been a median 10.7%; its worst year was 7.9%.
- Cash conversion 17 / 20
Free cash flow was positive in 10 of 10 years, at a median 13.1% of revenue.
- Discipline 18 / 20
The diluted share count fell 3.6% over five years; stock-based pay has been a median 1.3% of revenue.
AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.
Compare with peers
- GE HealthCare statistics
- Boston Scientific statistics
- Stryker Corporation statistics
- Koninklijke Philips NV statistics
- Medtronic statistics
Head to head: BDX vs GEHCBDX vs BSXBDX vs SYK
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies